Boan Biotech Begins International Phase III Trial Of Denosumab Biosimilars
One Product Is Already Approved For Marketing In China
Having already launched one of its denosumab biosimilar products in China, Boan Biotech has now commenced an international Phase III study to secure approval in Europe, the US and Japan.
